INS and type 2 diabetes mellitus: As hepatic overexpression of Cry1 lowered blood glucose concentrations and improved insulin sensitivity in insulin-resistant mice, molecules able to enhance cryptochrome activity might theoretically be useful to cope with type 2 diabetes [171].